No Data
No Data
Cotuo Biotech: Report for the first quarter of 2025
Cotto Biotech: 2024 Annual Report Summary
Cotuo Biotech: 2024 Annual Report
Beijing Scitop Bio-tech (300858.SZ) released its performance report for 2024, with a net income of 94.3561 million yuan, an increase of 0.94%.
Beijing Scitop Bio-tech (300858.SZ) released its annual report for 2024, with revenue of 0.303 billion yuan...
Beijing Scitop Bio-tech (300858.SZ) was subject to a Shareholding reduction of 6.0698 million shares by its Shareholders, Kerongda and Kehuidan.
Beijing Scitop Bio-tech (300858.SZ) announced that its Shareholder Ke Rong Da and specific Shareholder Ke Hui Da's Shareholding plan will be implemented...
Beijing Scitop Bio-tech (300858.SZ): Kairunda has cumulatively reduced its shareholding by 1%.
On December 13, Glonghui reported that Beijing Scitop Bio-tech (300858.SZ) announced that the company recently received a notification from Kerongda regarding the Shareholding reaching 1%. From November 29, 2024, to December 12, 2024, it reduced its shares by 400,000 shares through Trade transactions and by 2,235,000 shares through centralized bidding, totaling a Shareholding reduction of 1.0000%.